KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) EPS (Weighted Average and Diluted): 2018-2024

Historic EPS (Weighted Average and Diluted) for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Dec 2024 value amounting to -$0.38.

  • Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) fell 73.66% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.02, marking a year-over-year increase of 102.46%. This contributed to the annual value of -$0.38 for FY2024, which is 20.83% up from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$0.38 as of FY2024, which was up 20.83% from -$0.48 recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $0.61 in FY2020 and a low of -$0.86 during FY2022.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.48 (2023), whereas its average is -$0.57.
  • In the last 5 years, Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) spiked by 122.26% in 2020 and then crashed by 1,328.57% in 2022.
  • Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at $0.61 in 2020, then tumbled by 88.52% to $0.07 in 2021, then crashed by 1,328.57% to -$0.86 in 2022, then surged by 44.19% to -$0.48 in 2023, then rose by 20.83% to -$0.38 in 2024.